1. Home
  2. RVSB vs ALDX Comparison

RVSB vs ALDX Comparison

Compare RVSB & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

N/A

Current Price

$5.78

Market Cap

106.9M

Sector

Finance

ML Signal

N/A

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

N/A

Current Price

$1.38

Market Cap

88.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RVSB
ALDX
Founded
1923
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.9M
88.1M
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
RVSB
ALDX
Price
$5.78
$1.38
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$7.00
$5.50
AVG Volume (30 Days)
47.7K
637.5K
Earning Date
04-28-2026
05-01-2026
Dividend Yield
1.55%
N/A
EPS Growth
N/A
40.43
EPS
0.08
N/A
Revenue
N/A
N/A
Revenue This Year
$53.63
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$71.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.81
$1.07
52 Week High
$6.22
$5.93

Technical Indicators

Market Signals
Indicator
RVSB
ALDX
Relative Strength Index (RSI) 75.87 40.90
Support Level $5.23 $1.07
Resistance Level $5.84 $1.58
Average True Range (ATR) 0.10 0.07
MACD 0.06 -0.01
Stochastic Oscillator 95.16 23.91

Price Performance

Historical Comparison
RVSB
ALDX

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is the bank holding company. The Company's operations are managed along two operating segments, consisting of banking operations performed by the Bank and trust and investment services performed by the Trust Company. The Bank is engaged mainly in the business of attracting deposits from the general public and using such funds, together with other borrowings, to make various commercial business, commercial real estate, land, multi-family real estate, real estate construction and consumer loans. Additionally, the Trust Company offers trust and investment services. It has single operating segment.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: